A new article in Urology (“the Gold Journal”) has again pointed out the race-related discrepancies between the application of definitive treatments for prostate cancer, particularly between Caucasian-American and African-American men. This article by Moses et al. is based on data from > 300,000 men diagnosed with prostate cancer and listed in the Surveillance, Epidemiology and […]![]()
